NYSEAMERICAN:NSPR - InspireMD Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $1.35
  • Forecasted Upside: 281.03 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$0.35
▼ -0.01 (-2.74%)
1 month | 3 months | 12 months
Get New InspireMD Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for NSPR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NSPR

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$1.35
▲ +281.03% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for InspireMD in the last 3 months. The average price target is $1.35, with a high forecast of $2.00 and a low forecast of $0.70. The average price target represents a 281.03% upside from the last price of $0.35.
Buy
The current consensus among 2 contributing investment analysts is to buy stock in InspireMD.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/10/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/8/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/6/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/4/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/4/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/2/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/1/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/31/2020

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetDetails
10/16/2020Alliance Global PartnersInitiated CoverageBuy$0.70
i
5/13/2020HC WainwrightReiterated RatingBuy$2.00
i
Rating by Vernon Bernardino at HC Wainwright
3/11/2020HC WainwrightReiterated RatingBuy$5.00 ➝ $2.00
i
Rating by Vernon Bernardino at HC Wainwright
11/18/2019HC WainwrightReiterated RatingBuy$5.00
i
8/19/2019HC WainwrightReiterated RatingBuy$5.00
i
Rating by V. Bernardino at HC Wainwright
3/13/2019HC WainwrightReiterated RatingBuy
i
Rating by V. Bernardino at HC Wainwright
3/29/2016Rodman & RenshawLower Price TargetBuy$7,000.00 ➝ $5,250.00
i
3/29/2016Rodman & RenshawReiterated RatingBuy$7,000.00 ➝ $5,250.00
i
1/7/2016Rodman & RenshawInitiated CoverageBuy$7,000.00
i
1/7/2016HC WainwrightInitiated CoverageBuy$7,000.00
i
(Data available from 10/31/2015 forward)
InspireMD logo
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms in order to seal the aneurysms. InspireMD, Inc. distributes its products in Europe, Latin America, the Middle East, and Asia. The company is headquartered in Tel Aviv, Israel.
Read More

Today's Range

Now: $0.35
$0.34
$0.38

50 Day Range

MA: N/A

52 Week Range

Now: $0.35
$0.28
$1.64

Volume

514,368 shs

Average Volume

1,876,118 shs

Market Capitalization

$11.82 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A